SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-016615
Filing Date
2024-05-14
Accepted
2024-05-14 16:06:16
Documents
63
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q crvo20240331_10q.htm   iXBRL 10-Q 726594
2 EXHIBIT 31.1 ex_673636.htm EX-31.1 11190
3 EXHIBIT 31.2 ex_673637.htm EX-31.2 10316
4 EXHIBIT 32.1 ex_673638.htm EX-32.1 6285
5 EXHIBIT 32.2 ex_673639.htm EX-32.2 6298
11 image1.jpg GRAPHIC 12951
  Complete submission text file 0001437749-24-016615.txt   4038605

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA crvo-20240331.xsd EX-101.SCH 44447
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crvo-20240331_def.xml EX-101.DEF 297779
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE crvo-20240331_lab.xml EX-101.LAB 232580
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crvo-20240331_pre.xml EX-101.PRE 319147
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crvo-20240331_cal.xml EX-101.CAL 22052
67 EXTRACTED XBRL INSTANCE DOCUMENT crvo20240331_10q_htm.xml XML 478843
Mailing Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116
Business Address 20 PARK PLAZA SUITE 424 BOSTON MA 02116 (617) 744-4400
CervoMed Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 24944264
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)